Skip to main content
MYO logo

MYO · Myomo, Inc. · Metrics

Track MYO — free
$1.33 -0.01 (-0.75%) At close · Sep 9
Market Cap
$53.07M
Shares
39.61M

MYO metrics

69 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.33
Market cap
$53.07M

Price action

20 metrics
Price change (1W)
-6.3%
Price change (30D)
-6.3%
Price change (3M)
+2.3%
Price change (6M)
+98.5%
Price change (YTD)
+47.3%
Price change (1Y)
+34.9%
Trailing year
Price change (5Y)
-87.2%
52-week high
$1.86
52-week low
$0.64
Change from 52-week high
-28.0%
Change from 52-week low
+109.4%
Annualized volatility
97.5%
Annualized volatility (3M)
131.2%
Beta
2.0
RSI (14D)
46.1
Price vs SMA 50
+5.8%
Price vs SMA 200
+34.8%
Avg volume (3M)
792,743
Relative volume
0.6
Average dollar volume
$1.04M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
39.61M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
1.2×
reciprocal yield 83.8%
EV / EBITDA
EV / EBIT
P / sales
1.2×
reciprocal yield 81.5%
P / book
9.1
reciprocal yield 11.0%
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-27.3%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
0.8×
reciprocal yield 121.7%
EV / revenue historical average (5Y)
0.8×
reciprocal yield 121.7%
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
68.4%
Operating margin
-27.1%
Trailing 12 months
Net margin
-33.5%
Gross profit (TTM)
$29.57M
Operating profit (TTM)
−$11.70M
Net income (TTM)
−$14.51M
Trailing 12 months
Diluted EPS (TTM)
$-0.34
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$0.30

Growth

11 metrics
Revenue growth YoY
+21.3%
Year over year
Net income growth YoY
Revenue (TTM)
$43.26M
Trailing 12 months
EPS growth YoY
Shares change YoY
+2.7%
Year over year · more shares
Revenue CAGR (3Y)
+38.1%
Revenue CAGR (5Y)
+40.1%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-248.9%
Return on assets
-41.0%
Debt / equity
2.1
Current ratio
2.3
EBITDA (TTM)
Free cash flow (TTM)
Quick ratio
2.0
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
$1.47M
Latest balance sheet
Cash & equivalents
$11.22M
Total assets
$35.34M
Total debt
$11.98M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$7.11M
Capital expenditures (TTM)
$1.21M
R&D (TTM)
$6.50M
SG&A (TTM)
$18.78M
Stock compensation (TTM)
$2.79M
R&D / revenue
15.0%
Stock compensation / revenue
6.4%

Ownership (13F)

3 metrics
13F filers
79
13F filer change QoQ
-3
Institutional ownership
31.0%

Short interest

3 metrics
Short interest
2.8%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
44 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$51,479
Insider-sentiment score
36 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 1369290 CUSIP 62857J201 13F (30d) 50 filings 50 filers Visit website Investor relations